Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Pradaxa Bleeding Hemorrhaging | Lawsuits, Lawyers | Side Effects: Unusual bruising or bleeding, Pink or brown urine, Red or black tarry stools, Coughing up blood, Vomiting that resembles blood or looks like coffee grounds, Bleeding from the gums, Frequent

Pradaxa Lawsuit | Side Effects : Internal Bleeding, Internal Hemorrhaging, Bleeding

Pradaxa Lawsuit | Side Effects : Internal Bleeding, Internal Hemorrhaging, Bleeding

Have you or someone you care about suffered life-threatening internal bleeding or hemorrhaging side effects while taking Pradaxa? The defective drug lawyers at Parker Waichman LLP are currently investigating reports that some Pradaxa patients have experienced serious internal bleeding or hemorrhaging side effect episodes. In some instances, Pradaxa bleeding, internal bleeding / hemorrhaging side effects was not discovered in a timely manner, leading to death.

If you or someone you know experienced serious Pradaxa bleeding / hemorrhaging that might be associated with the drug, our defective drug lawyers want to hear from you today. We are currently offering FREE Pradaxa lawsuit consultations to all victims of Pradaxa bleeding / hemorrhaging side effects. To discuss your potential Pradaxa bleeding / hemorrhaging or other Pradaxa side effects lawsuit with an experienced defective drug lawyer, we urge you to contact us today.

Pradaxa Bleeding / Hemorrhaging Side Effects Reports

Pradaxa (dabigatran etexilate) is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent blood clots in patients with atrial fibrillation.

Symptoms of Pradaxa bleeding include:
  • Lethargy
  • Unusual bruising or bleeding / hemorrhaging
  • Pink or brown urine
  • Red or black tarry stools
  • Coughing up blood
  • Vomiting that resembles blood or looks like coffee grounds
  • Bleeding from the gums
  • Frequent nosebleeds
  • Joint pain or swelling
  • Headaches
  • Dizziness
  • Weakness and swelling of the arms, hands, feet, ankles or lower legs.
  • Death

No Antidote For Pradaxa Bleeding

No Antidote For Pradaxa Bleeding

Life Threatening Pradaxa

Pradaxa was brought to market with great fanfare, with its maker touting it as being safer than traditional blood thinners, like warfarin (brand names Coumadin, Jantoven and Marfarin). And it is true that Pradaxa will not react with certain foods the way warfarin will to increase the likelyhood of bleeding events. However, warfarin bleeding can be stopped via the administration of vitamin K. There is no antidote for Pradaxa bleeding at this time, making Pradaxa bleeding events potentially far more deadly.

Pradaxa Side Effects May Have Caused Patient Deaths From Bleeding / Hemorrhaging

Pradaxa Side Effects May Have Caused Patient Deaths From Bleeding / Hemorrhaging

Have you suffered side effects from taking Pradaxa?

In September 2011, Pradaxa became the subject of an investigation in New Zealand after as many as five elderly Pradaxa patients reportedly died as a result of internal bleeding / hemorrhaging. Another 36 patients reportedly suffered bouts of serious internal bleeding / hemorrhaging. New Zealand media outlets reported that some families claimed the chain of events leading to their relatives' deaths began when they switched from warfarin to Pradaxa, and infections set in after their conditions had deteriorated to the point of hospital admission.

The New Zealand reports came weeks after regulators in Japan asked the maker of Pradaxa to notify doctors about potentially deadly bleeding / hemorrhaging in some Pradaxa patients. According to a letter sent to Boehringer Ingelheim by the country's health ministry, between March 14 and August11, 81 elderly patients taking Pradaxa suffered heavy bleeding / hemorrhaging, leading to five deaths. Japanese officials suggested that patients older than 70 may need a lower dose of Pradaxa. Bleeding / hemorrhaging is also a side effect of older blood thinners, such a warfarin. But warfarin bleeding can be treated with vitamin K. There is no antidote available for bleeding caused by Pradaxa and similar drugs, known as direct thrombin inhibitors.

Large Study Finds Pradaxa Carries Greater GI Bleeding Risks Than Warfarin

The FDA has completed a study involving Medicaid patients that compared Pradaxa, which is made by Boehringer Ingelheim, to warfarin, both blood-thinning drugs. The study endeavored to understand the risk for ischemic or clot-related stroke, bleeding in the brain, major gastrointestinal (GI) bleeding, myocardial infarction (MI), and death seen in people who take the medications. The research included data from more than 134,000 Medicare patients, 65 years or older.

The study revealed that, among new users of blood-thinning drugs, Pradaxa was tied to a lower risk of clot-related strokes, bleeding in the brain, and death; however, when compared to people who took warfarin, an increased risk of major gastrointestinal bleeding was seen in Pradaxa users. The MI risk was similar in both drugs and was consistent with Pradaxa’s clinical trial results.

This study was based on a significantly larger and older patient population than was used in the agency’s prior review of post-market data, and also used more sophisticated analytical methods for collection and analysis. The FDA has made no changes to the current Pradaxa label or recommendations for the drug’s use.

Pradaxa Lawsuit | Legal Help for Victims of Pradaxa Bleeding

If you or a loved one suffered serious Pradaxa bleeding / hemorrhaging while taking the drug, you may have valuable legal rights. To learn how our Pradaxa bleeding lawyers can help you file a Pradaxa Lawsuit, please fill out our online form or call 1-800-YOURLAWYER (1-800-968-7529) today.

More on Eliquis


Pradaxa Bleeding Side Effects

Pradaxa Side Effects

Xarelto (Rivaroxaban) Blood Clot Side Effects May Lead to Personal Injury Lawsuits

Xarelto (Rivaroxaban)

 Pradaxa Bleeding Following Atrial Fibrillation Ablation

Pradaxa/Atrial Fibrillation




PradaxaRSS Feed

Pradaxa Antidote Does Not Eliminate Bleeding Risks

Jan 24, 2017
Pradaxa Antidote, Praxbind, Only Available in Hospitals The bleeding risks associated with Pradaxa (dabigatran etexilate) are fairly well known in the United States following a number of serious injury reports and deaths. Pradaxa was approved by the U.S. Food and Drug Administration (FDA) in 2010 and is manufactured by drug maker Boehringer Ingelheim. Typically, the body forms clots to avoid deadly, uncontrolled bleeding, a process that involves an array of clotting...

Pradaxa Patients Face Bleeding Risks Despite Antidote

Jan 18, 2017
Pradaxa Patients Face Bleeding Risks Despite Antidote The bleeding risk for people taking the blood-thinning drug Pradaxa is well documented, and the risk persists despite a recently developed bleeding antidote. Many patients allege that the drug maker was reckless in introducing Pradaxa to the market with a bleeding reversal agent. Pradaxa: First of the New Blood Thinners For many years, warfarin was the only option for patients who needed an anticoagulant. But patients...

Pradaxa Safety Questioned

Sep 13, 2016
Plaintiffs in the Pradaxa litigation are calling into question whether or not the blood thinner is safe. Pradaxa, known generically as dabigatran, is manufactured by Boehringer Ingelheim to reduce the risk of blood clots and related injuries, such as stroke and pulmonary embolism, in patients with atrial fibrillation. As with all anticoagulants, Pradaxa carries a risk of excessive bleeding. However, the drug has raised safety questions due to the lack of an antidote to reverse the...

BMJ Criticizes Pradaxa's Approval Process, Urges Dose Monitoring

Jul 24, 2014
Pradaxa (dabigatran), an anticoagulant manufactured by Boehringer Ingelheim, has been the subject of safety concerns in the short time that it has been on the market. Now, four reports published in the British Medical Journal (BMJ) criticize the way Pradaxa was approved, stating that BI failed to fully inform regulators of important findings. Pradaxa is used to reduce the risk of blood clot, stroke and heart attack in patients who have nonvalvular atrial fibrillation (AF). It was the first of...

Pradaxa Carries Higher Risk for Gastrointestinal Bleeding than Warfarin

May 16, 2014
Results of a recently completed Food and Drug Administration (FDA) study of the blood-thinners Pradaxa (dabigatran) and warfarin found an increased risk of major gastrointestinal bleeding with Pradaxa as compared to warfarin. Pradaxa and warfarin (Coumadin) are used to reduce the risk of stroke and blood clots in patients with a common type of abnormal heart rhythm called non-valvular atrial fibrillation (AF). The study compared the risk of ischemic or clot-related stroke, bleeding in the...

More Pradaxa News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo